Unlike many online publications, we don’t have a paywall or run banner advertising, because we want to keep our journalism open, without influence or the need to chase traffic. UK - based Balderton Capital has led a $ 30 m series D funding round for the Swiss health tech company Sophia Genetics . The company 's SOPHiA software platform is used to analyse patients ' DNA to diagnose illnesses and gain a better understanding of their health needs . It claims the overall patient data collected will also lead to better diagnosis of others . A number of other companies are looking to use AI technology in the healthcare sector , such as DeepMind Technologies , which is working with the British National Health Service to develop a patient care management system relying on machine learning .
UK - based Balderton Capital has led a $ 30 m series D funding round for the Swiss health tech company Sophia Genetics . The company 's SOPHiA software platform is used to analyse patients ' DNA to diagnose illnesses and gain a better understanding of their health needs . It claims the overall patient data collected will also lead to better diagnosis of others . A number of other companies are looking to use AI technology in the healthcare sector , such as DeepMind Technologies , which is working with the British National Health Service to develop a patient care management system relying on machine learning .